Interesting hypothesis in a rodent model of myxomatous degeneration.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Cardiac - Other
May 11, 2020
April 25, 2020
A timely article addressing common questions related to the COVID pandemic, particularly regarding preoperative decision-making for pediatric/congenital heart surgery.
April 13, 2020
Topical review on the epidemic in Britain, with a number of observations that relate to the cardiothoracic surgeons and all healthcare professionals:
-The assertion that the National Health Service in Britain was overrun PRIOR to the pandemic.
-The assertion that acute angina is now being undertreated.
March 26, 2020
In a cohort of 416 patients hospitalized with COVID-19, nearly 20% had elevated troponins indicating myocardial injury. These patients also had a host of other serum and radiographic abnormalities, were older, had more comorbidities, and more often required ventilatory support. Their mortality rate was 51% compared to 4.5% for other hospitalized pa
March 1, 2020
A very easy-to-read editorial that digests a manuscript on the IMPROVE study.
February 20, 2020
The authors revisit the older, somewhat misinterpreted hypothesis of cocoa and vasodilation. The title may again be misinterpreted by the general media as an encouragement to gorge on HIGH CALORIE, HIGH FAT nutrients
January 8, 2020
A medium size RCT with encouraging surgical outcomes in the era of TAVI expansion.....
December 9, 2019
Given the escalating importance of atrial fibrillation for surgeons, this genomics article may be of considerable interest in future.
December 4, 2019
Well-presented Canadian prospective study juxtaposing a combination of Wells scoring and dimers to the imaging gold standard.
It was particularly fascinating to read the referenced assertion that:
November 22, 2019
Puzzling subgroup from the GALILEO trial, which appears in the same issue of the periodical as an article that discredits the use of rivaroxaban as thromboprevention strategy :